SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-2.83%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$332M
AUM Growth
+$55.4M
(+20%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
33.3%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
251
New
43
Increased
42
Reduced
59
Closed
32
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$40.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$31.8M |
| 3 |
Amgen
AMGN
|
$17.5M |
| 4 |
Eli Lilly
LLY
|
$15.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
$7.73M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$6.04M |
| 2 |
Abbott
ABT
|
$4.77M |
| 3 |
Regenxbio
RGNX
|
$3.98M |
| 4 |
CELG
Celgene Corp
CELG
|
$3.94M |
| 5 |
United Therapeutics
UTHR
|
$3.32M |
Sector Composition
| 1 | Healthcare | 93.08% |
| 2 | Consumer Staples | 0.27% |
| 3 | Technology | 0.16% |
| 4 | Energy | 0% |
| 5 | Industrials | 0% |
